Colin Collins

Biography

Dr Collins is a Professor at the University of British Columbia and a Senior Scientist at the Vancouver Prostate Centre where he directs The Laboratory for Advanced Genome Analysis He is an associate adjunct professor at the University of California San Francisco Comprehensive Cancer Center His research is best described as translational genomics where mathematics genomics computer science and clinical science converge in diagnostics and therapeutics He identified and patented of a suite of DNA based biomarkers for predicting a prostate cancer patient’s risk of metastasis He invented and patented End Sequence Profiling ESP the forerunner of pairedend sequencing to determine the physical structure of tumour genomes Dr Collins is now integrating arraybased technologies and next generation sequencing technologies to make personalized oncology a reality in the near term He has received multiple patents and awards including the California Cancer Research Programs Cornelius L Hopper Scientific Achievement Award for Innovation Dr Collins is a Professor at the University of British Columbia and a Senior Scientist at the Vancouver Prostate Centre where he directs The Laboratory for Advanced Genome Analysis He is an associate adjunct professor at the University of California San Francisco Comprehensive Cancer Center His research is best described as translational genomics where mathematics genomics computer science and clinical science converge in diagnostics and therapeutics He identified and patented of a suite of DNA based biomarkers for predicting a prostate cancer patient’s risk of metastasis He invented and patented End Sequence Profiling ESP the forerunner of pairedend sequencing to determine the physical structure of tumour genomes Dr Collins is now integrating arraybased technologies and next generation sequencing technologies to make personalized oncology a reality in the near term He has received multiple patents and awards including the California Cancer Research Programs Cornelius L Hopper Scientific Achievement Award for Innovation

Research Interest

His research is best described as translational genomics where mathematics, genomics, computer science, and clinical science converge in diagnostics and therapeutics. He identified and patented of a suite of DNA based biomarkers for predicting a prostate cancer patient’s risk of metastasis. He invented and patented End Sequence Profiling (ESP) the forerunner of paired-end sequencing to determine the physical structure of tumour genomes. Dr Collins is now integrating array-based technologies and next generation sequencing technologies to make personalized oncology a reality in the near term.